Riskpilot← Back to searchSign inGet full accessPLEIELEIE AS
ASActiveOrg 823729332Byggveien 17, 3223 SandefjordWholesale of pharmaceutical and medical goods · NACE 4646Est. 20190 employees
Revenue 2024
NOK 98K
-14% vs 2023
EBITDA margin
15.8%
+149% vs 2023
Equity ratio
-42.0%
Financial strength
Net profit 2024
NOK -22K
+16% vs 2023
| Revenue | NOK 98K | -14% |
| EBITDA | NOK 15K | +149% |
| Net profit | NOK -22K | +16% |
| Total assets | NOK 189K | +26% |
| Equity | NOK -79K | -39% |
| Employees | 0 | — |
Legal name
PLEIELEIE AS
Org number
823729332
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. oktober 2019
Share capital
NOK 40 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Tre styremedlemmer i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Å drive salg og utleie av hjelpemidler, materiell og utstyr innenfor helse og omsorg. Herunder også utleie av personell, samt alt som naturlig hører til dette.
Address
Byggveien 17, 3223 Sandefjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 5 | 45 | 115 | 98 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −13 | −3 | −17 | 6 | 15 |
| Depreciation & amort. | −5 | −6 | −17 | −33 | −38 |
| EBIT | −19 | −9 | −35 | −26 | −22 |
| Net financials | −2 | 0 | −0 | −0 | −0 |
| Profit before tax | −20 | −9 | −35 | −27 | −22 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −20 | −9 | −35 | −27 | −22 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 31 | 32 | 106 | 149 | 189 |
| Equity | 14 | 4 | −31 | −57 | −79 |
| Long-term debt | 15 | 28 | 95 | 202 | 248 |
| Short-term debt | 3 | 0 | 42 | 4 | 20 |
| Total debt | 17 | 28 | 137 | 206 | 268 |
EBITDA margin
15.8%
This company
15.8%
Market median
+0% vs market
20202024
Equity ratio
-42.0%
This company
38.2%
Market median
-210% vs market
20202024
Return on equity
-2227900.0%
This company
18.4%
Market median
-12108252% vs market
20202024
Net profit margin
-22.7%
This company
8.1%
Market median
-380% vs market
20202024
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20202024
Debt / equity
3.38×
This company
0.62×
Market median
-445% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HB Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hele Holding As
PLEIELEIE AS Board members of PLEIELEIE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Bakk Eikås | Chief Executive Officer | 0 companies |
| Thomas Kraus | Chairman | 0 companies |
| Grethe Ingeborg Kraus | Board of Directors | 0 companies |
| Lena Marie Bakk Eikås | Board of Directors | 0 companies |